• Metronidazole Infusion Bp 500mg/100ml GMP
  • Metronidazole Infusion Bp 500mg/100ml GMP
  • Metronidazole Infusion Bp 500mg/100ml GMP
  • Metronidazole Infusion Bp 500mg/100ml GMP
  • Metronidazole Infusion Bp 500mg/100ml GMP
  • Metronidazole Infusion Bp 500mg/100ml GMP

Metronidazole Infusion Bp 500mg/100ml GMP

Application: Internal Medicine
Usage Mode: Liquid Injection
Suitable for: Adult
State: Liquid
Shape: Liquid Injection
Type: Biological Products
Samples:
US$ 0.01/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Gold Member Since 2019

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company

Basic Info.

Model NO.
500mg/100ml
Pharmaceutical Technology
Chemical Synthesis
Price
Low Price
Market
Africa
Transport Package
Carton
Specification
500mg/100ml
Trademark
OEM
Origin
China
HS Code
3004909099
Production Capacity
100000000PCS

Product Description

Metronidazole Infusion Bp 500mg/100ml GMP
Element
The main ingredient of this product is metronidazole.
traits
This product is a colorless or slightly yellow clear liquid.

Indications
This product is mainly used for the treatment of anaerobic infection.

Specification
10ml: 50mg.

Dosage
Intravenous drip.

1. The usual dose for adults: for anaerobic infection, intravenous administration should be 15mg/kg of body weight for the first time (1g for a 70kg adult), and the maintenance dose should be 7.5mg/kg of body weight, intravenously every 6-8 hours.

2. Usual dosage for children: the injection dosage for anaerobic infection is the same as that for adults.

Adverse reactions
1. Adverse reactions occurred in 15%-30% of cases, the most common of which were gastrointestinal reactions, including nausea, vomiting, loss of appetite, abdominal cramps, and generally did not affect treatment; neurological symptoms included headache, dizziness, and occasionally paresthesia, limb Numbness, ataxia, polyneuritis, etc., large doses can cause convulsions.

2. In a few cases, urticaria, flushing, itching, cystitis, dysuria, metallic taste in the mouth and leukopenia, etc., are all reversible and recover spontaneously after stopping the drug.

Patients with active central nervous system diseases and blood diseases are disabled.

1. This product can inhibit the metabolism of warfarin and other oral anticoagulants, strengthen their effects, and prolong the prothrombin time.

2. Simultaneous application of drugs that induce liver microsomal enzymes such as phenytoin and can enhance the metabolism of this product, reduce the blood concentration, and slow down the excretion of phenytoin.

3. Simultaneous application of cimetidine and other drugs that inhibit the activity of liver microsomal enzymes can slow down the metabolism and excretion of this product in the liver, and prolong the serum half-life of this product. The dose should be adjusted according to the results of blood concentration determination.

4. This product interferes with the metabolism of disulfide, and patients who use the two together may experience mental symptoms after drinking. Therefore, it is not suitable for those who use disulfiram within 2 weeks to use this product.

5. This product can interfere with the determination results of aminotransferase and LDH, and can reduce the level of cholesterol and triglyceride.
Carcinogenic to some animals.

Metronidazole Infusion Bp 500mg/100ml GMPMetronidazole Infusion Bp 500mg/100ml GMPMetronidazole Infusion Bp 500mg/100ml GMP

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2019

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
Number of Employees
150
Year of Establishment
2004-01-16